Wildcat Capital Management, LLC - Q1 2016 holdings

$288 Million is the total value of Wildcat Capital Management, LLC's 28 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 68.4% .

 Value Shares↓ Weighting
KITE  KITE PHARMA INC$108,260,000
-25.5%
2,358,0840.0%37.66%
-8.2%
CSGP SellCOSTAR GROUP INC$47,809,000
-9.7%
254,072
-0.8%
16.63%
+11.3%
NK  NANTKWEST INC$36,953,000
-52.6%
4,495,4950.0%12.85%
-41.5%
BuySPDR S&P 500 ETF TRput$21,950,000
+76.2%
106,800
+21.4%
7.64%
+117.2%
SRNE  SORRENTO THERAPEUTICS INC$14,115,000
-38.2%
2,623,5330.0%4.91%
-23.9%
A104PS BuyHILTON WORLDWIDE HOLDINGS INC$11,373,000
+108.4%
505,000
+98.0%
3.96%
+156.9%
EDIT NewEDITAS MEDICINE INC$8,558,000247,768
+100.0%
2.98%
MDXG  MIMEDX GROUP INC$8,350,000
-6.7%
955,3650.0%2.90%
+15.0%
NewBARCLAYS BK PLCput$5,930,000336,600
+100.0%
2.06%
LPLA  LPL FINL HLDGS INC$5,125,000
-41.8%
206,6470.0%1.78%
-28.3%
TACO  DEL TACO RESTAURANTS INC$3,373,000
-3.0%
326,4780.0%1.17%
+19.6%
CSAL  COMMUNICATIONS SALES & LEASE IN$3,360,000
+19.1%
151,0000.0%1.17%
+46.9%
NewISHARES TRcall$2,621,00010,050
+100.0%
0.91%
ARCC NewARES CAPITAL CORP$2,597,000175,000
+100.0%
0.90%
NMFC NewNEW MTN FIN CORP$2,266,000179,278
+100.0%
0.79%
GSBD NewGOLDMAN SACHS BDC INC$1,960,000100,000
+100.0%
0.68%
AAVL  AVALANCHE BIOTECHNOLOGIES IN$1,216,000
-45.7%
235,2640.0%0.42%
-33.1%
CMCSA  COMCAST CORP-CLASS Acl a$720,000
+8.3%
11,8350.0%0.25%
+33.0%
FB  FACEBOOK INC-Acl a$703,000
+9.0%
6,1630.0%0.24%
+34.6%
NewBLACKROCK CAPITAL INVESTMENT$129,00013,671
+100.0%
0.04%
DHX  DHI GROUP INC$126,000
-11.9%
15,6050.0%0.04%
+10.0%
COT NewCOTT CORP QUE$12,000839
+100.0%
0.00%
ExitMARKET VECTORS ETF TRcall$0-46,500
-100.0%
-0.19%
ExitMARKET VECTORS ETF TRput$0-53,500
-100.0%
-0.22%
ExitPOWERSHS DB US DOLLAR INDEXput$0-75,000
-100.0%
-0.36%
IBB ExitISHARES TRnasdq biotec etf$0-9,000
-100.0%
-0.86%
ExitISHARES TRcall$0-65,950
-100.0%
-1.11%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2016-12-02
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COSTAR GROUP INC32Q3 202248.3%
UROGEN PHARMA LTD26Q3 202317.3%
META PLATFORMS INC26Q3 20239.9%
ALLOGENE THERAPEUTICS INC18Q3 202322.4%
GOOSEHEAD INSURANCE INC -A18Q3 202315.4%
SABINE RTY TRUST18Q3 202111.3%
LPL FINL HLDGS INC18Q1 201912.7%
PLAYA HOTELS & RESORTS NV18Q3 20213.4%
NANTKWEST INC17Q3 201922.0%
SORRENTO THERAPEUTICS INC17Q2 20197.0%

View Wildcat Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Wildcat Capital Management, LLC Q1 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Skillz Inc.January 05, 202319,596,9885.6%
UroGen Pharma Ltd.February 14, 2022533,1392.4%
Skillz Inc.March 08, 202121,832,0227.5%
NantKwest, Inc.February 13, 2018808,9741.0%
Sorrento Therapeutics, Inc.February 13, 20181,738,2322.2%

View Wildcat Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
32024-04-08
SC 13G2024-04-08
13F-HR2024-02-13
13F-HR2023-11-09
PX14A6G2023-11-03
13F-HR2023-08-11
13F-HR/A2023-08-10
13F-HR2023-05-12
13F-HR2023-02-07
SC 13D/A2023-01-05

View Wildcat Capital Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (287504000.0 != 287506000.0)
  • The reported has been restated
  • The reported has been amended

Export Wildcat Capital Management, LLC's holdings